Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Vaccine prospects for amebiasis.

Chaudhry OA, Petri WA Jr.

Expert Rev Vaccines. 2005 Oct;4(5):657-68. Review.

PMID:
16221067
2.

Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.

Houpt E, Barroso L, Lockhart L, Wright R, Cramer C, Lyerly D, Petri WA.

Vaccine. 2004 Jan 26;22(5-6):611-7.

PMID:
14741152
4.

The future for vaccine development against Entamoeba histolytica.

Quach J, St-Pierre J, Chadee K.

Hum Vaccin Immunother. 2014;10(6):1514-21. doi: 10.4161/hv.27796. Epub 2014 Feb 6. Review.

PMID:
24504133
6.
7.

Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine.

Barroso L, Abhyankar M, Noor Z, Read K, Pedersen K, White R, Fox C, Petri WA Jr, Lyerly D.

Vaccine. 2014 Feb 26;32(10):1218-24. doi: 10.1016/j.vaccine.2013.06.056. Epub 2013 Jul 1.

8.
9.

Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.

Stanley SL Jr, Blanchard JL, Johnson N, Foster L, Kunz-Jenkins C, Zhang T, Tian K, Cogswell FB.

Vaccine. 1995 Jul;13(10):947-51.

PMID:
7483769
10.

Host-pathogen interaction in amebiasis and progress in vaccine development.

Huston CD, Petri WA Jr.

Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):601-14. Review.

PMID:
9832261
11.

Entamoeba histolytica: from adherence to enteropathy.

Ravdin JI.

J Infect Dis. 1989 Mar;159(3):420-9. Review.

PMID:
2536786
12.
13.

Progress towards development of a vaccine for amebiasis.

Stanley SL Jr.

Clin Microbiol Rev. 1997 Oct;10(4):637-49. Review.

16.

Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.

Gaucher D, Chadee K.

Parasite Immunol. 2003 Feb;25(2):55-8. Review.

17.

Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.

Roncolato EC, Teixeira JE, Barbosa JE, Zambelli Ramalho LN, Huston CD.

Infect Immun. 2015 Feb;83(2):713-20. doi: 10.1128/IAI.02490-14. Epub 2014 Dec 1.

18.

VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Tachibana H, Watanabe K, Cheng XJ, Tsukamoto H, Kaneda Y, Takeuchi T, Ihara S, Petri WA Jr.

Infect Immun. 2003 Aug;71(8):4313-9.

19.

Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica.

Ravdin JI, Jackson TF, Petri WA Jr, Murphy CF, Ungar BL, Gathiram V, Skilogiannis J, Simjee AE.

J Infect Dis. 1990 Sep;162(3):768-72.

PMID:
2388003
20.

Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.

Miller-Sims VC, Petri WA Jr.

Curr Opin Immunol. 2002 Oct;14(5):549-52. Review.

PMID:
12183151
Items per page

Supplemental Content

Write to the Help Desk